{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:13:30Z","timestamp":1786997610606,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":108,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.toxrep.2022.04.021","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T02:48:43Z","timestamp":1650595723000},"page":"927-936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Toxicity and toxicokinetic assessment of an anti-tubercular drug pretomanid in cynomolgus monkeys"],"prefix":"10.1016","volume":"9","author":[{"given":"Rebecca","family":"Bruning-Barry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Ambroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dillberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian J.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxrep.2022.04.021_bib1","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/35016103","article-title":"A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis","volume":"405","author":"Stover","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.toxrep.2022.04.021_bib2","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1126\/science.1164571","article-title":"PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release","volume":"322","author":"Singh","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.toxrep.2022.04.021_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4161\/cib.2.3.7926","article-title":"The mechanism of action of PA-824: novel insights from transcriptional profiling","volume":"2","author":"Manjunatha","year":"2009","journal-title":"Commun. Integr. Biol."},{"key":"10.1016\/j.toxrep.2022.04.021_bib4","unstructured":"World Health Organization (WHO). 2021. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis, 27\u201329 October 2020. WHO, Geneva."},{"key":"10.1016\/j.toxrep.2022.04.021_bib5","series-title":"Global Tuberculosis Report 2020","author":"World Health Organization (WHO)","year":"2020"},{"key":"10.1016\/j.toxrep.2022.04.021_bib6","series-title":"Global Tuberculosis Report 2018","author":"World Health Organization (WHO)","year":"2018"},{"key":"10.1016\/j.toxrep.2022.04.021_bib7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of highly drug-resistant pulmonary tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.toxrep.2022.04.021_bib8","article-title":"The pipeline of new molecules and regimens against drug-resistant tuberculosis","volume":"25","author":"Black","year":"2021","journal-title":"J. Clin. Tube Other Mycobact. Dis."},{"key":"10.1016\/j.toxrep.2022.04.021_bib9","unstructured":"J. Trutter, R. Dalefield, 7-Day Gavage Study with PA-824 in Cynomolgus Monkeys Covance Lab. Inc. 2004."},{"key":"10.1016\/j.toxrep.2022.04.021_bib10","unstructured":"J. Trutter, R. Dalefield, 2-Week Nasogastric Gavage Toxicity and Toxicokinetic Study with PA-824 in Cynomolgus Monkeys with a Minimum 2-Week Recovery Period Covance Lab. Inc. 2005."},{"key":"10.1016\/j.toxrep.2022.04.021_bib11","unstructured":"E. Goldenthal, PA-824: A 3-Month Oral Toxicity Study in Cynomolgus Monkeys with a 3-Month Recovery MPI Res. Inc. 2008."},{"key":"10.1016\/j.toxrep.2022.04.021_bib12","unstructured":"S. Oneda ,PA-824: A 13-Week Study to Evaluate Reproductive Function and Lenticular Lesions in Male Cynomolgus Monkeys SNBL USA, Ltd 2009."},{"key":"10.1016\/j.toxrep.2022.04.021_bib13","article-title":"39-week repeat-dose toxicology and toxicokinetic study with PA-824 in mature cynomolgus macaques with a 12-week recovery period","author":"Gahagen","year":"2015","journal-title":"SRI Int."},{"key":"10.1016\/j.toxrep.2022.04.021_bib14","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.1971.03190250058033","article-title":"Dark urine related to metronidazole therapy","volume":"218","author":"Bruce","year":"1971","journal-title":"JAMA"},{"key":"10.1016\/j.toxrep.2022.04.021_bib15","unstructured":"Mylan Pretomanid [Label. ], Vol. 212862Orig1 2019 s000."},{"key":"10.1016\/j.toxrep.2022.04.021_bib16","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1128\/AAC.00106-09","article-title":"Safety, tolerability, and pharmacokinetics of PA-824 in healthy subjects","volume":"53","author":"Ginsberg","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.toxrep.2022.04.021_bib17","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/cpdd.898","article-title":"Phase 1 study of the effects of the tuberculosis treatment pretomanid, alone and in combination with moxifloxacin, on the QTc interval in healthy volunteers","volume":"10","author":"Li","year":"2021","journal-title":"Clin. Pharm. Drug Dev."},{"key":"10.1016\/j.toxrep.2022.04.021_bib18","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1128\/AAC.06125-11","article-title":"Phase II dose-ranging trial of the early bactericidal activity of PA-824","volume":"56","author":"Diacon","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.toxrep.2022.04.021_bib19","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/AAC.01354-09","article-title":"Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosis patients","volume":"54","author":"Diacon","year":"2010","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750022001044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750022001044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T03:16:29Z","timestamp":1718507789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750022001044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":19,"alternative-id":["S2214750022001044"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2022.04.021","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicity and toxicokinetic assessment of an anti-tubercular drug pretomanid in cynomolgus monkeys","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2022.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}